Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Glazer has been diagnosed with anxiety, depression, ADHD and bipolar disorder. His mental health playbook includes frequent ...

They call it masking. That’s when someone with ADHD or autism tries to act how you expect them to, but not in a way that makes sense for them. They tell us it can be exhausting.

Supernus (SUPN) Pharmaceuticals announced that ... Qelbree is approved for use in patients ages 6 years and older with ADHD. Published first on TheFly – the ultimate source for real-time ...

Jessica Booth is a New York-based freelance writer who regularly writes about health, wellness, parenting, food, travel, beauty and more for a variety of publications. She currently writes for ...

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition that is typically diagnosed during childhood. ADHD can also be diagnosed in ...

Qelbree® is a novel nonstimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD). Knight entered into an agreement in December 2023 with Supernus Pharmaceuticals ...